R

Roanoke Heart Institute | Roanoke, VA

Research site
(Unclaimed)
Location
201 McClanahan St South West, Roanoke, Virginia, United States of America

Site insights

Top conditions

Top treatments

sodium
Bococizumab
Acoramidis
Celecoxib
Flurpiridaz F 18
Inclisiran
Tolvaptan
Triglycerides
Naproxen
18F

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 11 total trials

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation (HERMES)

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get z...

Enrolling
Heart Failure
Drug: Ziltivekimab
Drug: Placebo

CKJX839D12302 is a pivotal Phase III study designed to test the hypothesis that treatment with inclisiran sodium 300 milligram (mg) subcutaneous (s.c...

Enrolling
Primary Prevention of Atherosclerotic Cardiovascular Disease
Drug: Placebo in 1.5ml
Drug: Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL

Open-Label Extension and Safety Monitoring Study of Acoramidis (AG10) in Participants with Symptomatic Transthyretin Amyloid Cardiomyopathy Who Compl...

Active, not recruiting
Amyloid Cardiomyopathy, Transthyretin-Related
Drug: Acoramidis (AG10)

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Placebo
Drug: Inclisiran sodium 300 mg

Trial sponsors

Novartis logo
Pfizer logo
E
General Electric (GE) logo
Kowa logo
Lantheus Medical Imaging logo
Novo Nordisk logo
Otsuka logo
Viatris logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems